Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 460

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 460
---
 |        | 2023 |     |   |        |   |
|:--------------------------------|:----|:------------------|-------:|:-----|:----|:--|-------:|:--|
| Operating activities            |     | $                 | (1,507 | )    |     | $ | (3,651 | ) |
| Investing activities            |     | $                 |   (321 | )    |     | $ |      — |   |
| Financing activities            |     | $                 |  1,826 |      |     | $ |  3,574 |   |

261

Operating Activities Cash used in operating activities for the nine months ended September 30, 2024 of $1.8 million was primarily driven by our net loss of $7.0 million, adjusted for non -cashcharges of $3.6 million and net cash inflows of $1.6 million provided by changes in our operating assets and liabilities. Non -cashcharges primarily consisted of non -cashinterest expense of $3.3 million, partially offset by change in the fair value of related party convertible loan of $0.28 million. The main driver of the cash inflows from the changes in operating assets and liabilities was primarily related to an increase in accounts payable of $0.7 million and in accrued liabilities of $1.6 million and a decrease in prepaid expenses and other current assets of $0.7 million. Cash used in operating activities for the nine months ended September 30, 2023 of $3.7 million was primarily driven by our net loss of $7.0 million, adjusted for non -cashcharges of $2.3 million and net cash inflows of $1.1 million provided by changes in our operating assets and liabilities. Non -cashcharges primarily consisted of non -cashinterest expense of $2.2 million, partially offset by change in the fair value of related party convertible loan of $0.04 million. The main driver of the cash inflows from the changes in operating assets and liabilities was primarily related to a decrease in accounts payable of $0.4 million and an increase accrued liabilities of $0.7 million. Financing Activities Cash provided by financing activities was $1.8 million for the nine months ended September 30, 2024, which consisted primarily of net proceeds from the issuance of senior notes of $2.1 million, offset by payment of deferred offering costs of $0.15 million and repayment